Statistics

Total Visits

Views
Efficacy and safety of sorafenib in combination with mammalian target of rapamycin inhibitors for recurrent hepatocellular carcinoma after liver transplantation74

Select a period of time:

Number of views in the range

Views
Efficacy and safety of sorafenib in combination with mammalian target of rapamycin inhibitors for recurrent hepatocellular carcinoma after liver transplantation19

Views

Views
November 20253
December 20251
January 20265
February 20260
March 20267
April 20260
May 20263
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States12
Argentina3
Bolivia1
Ecuador1
Finland1
Senegal1
 

Top cities views

Views
San Jose4
Ashburn2
Cochabamba1
Dakar1
Helsinki1
Macará1
Merlo1
Miami1
Monte Grande1
New York1